The federal government has shown substantial interest in taking a variety of measures aimed at lowering U.S. prescription drug prices to align with the lowest prices available for the same drugs in comparably developed nations (so called “most favored nation” pricing).
All entries for: EyePoint Inc
March 5, 2026
EyePoint Inc
Negative Outlook
Watertown, MA
51-200 employees
The Inflation Reduction Act of 2022 and other changes in healthcare law may impact the prices we are able to obtain for our products and our obligations to make payments to the government.
Disease Area: Chronic Disease, Rare Diseases
Drug Type: Small Molecule